Bioptik TechnologyROCO:4161 68 Days Payable is 29.46 as of Dec. 2025, which is 45% below its 10-year median of 53.17. GuruFocus rates ROCO:4161 with a GF Score™ of 68/100 and a GF Value™ of NT$27.79 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Bioptik Technology ranks worse than 84.55% on this metric.
The historical rank and industry rank for Bioptik Technology's Days Payable or its related term are showing as below:
ROCO:4161'
s Days Payable Range Over the Past 10 Years
Min: 30.51 Med: 53.17 Max: 62.16
Current: 30.51
During the past 13 years, Bioptik Technology's highest Days Payable was 62.16. The lowest was 30.51. And the median was 53.17.
ROCO:4161's Days Payable is ranked worse than 84.55% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ROCO:4161: 30.51
Bioptik Technology's Days Payable
declined
from Dec. 2024 (31.02) to Dec. 2025 (29.46).
It may suggest that Bioptik Technologyaccelerated paying its suppliers.
Bioptik Technology Days Payable Related Terms
Bioptik Technology Days Payable Historical Data
* Premium members only.
The historical data trend for Bioptik Technology's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4161 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Bioptik Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioptik Technology Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's Days Payable distribution charts can be found below:
* The bar in red indicates where Bioptik Technology's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bioptik Technology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioptik Technology (ROCO:4161) has a Days Payable of 29.46 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bioptik Technology and its competitors. This is 45% below median its historical median of 53.17. Over the past decade, Bioptik Technology's Days Payable has ranged from 30.51 to 62.16. According to the industry distribution chart, Bioptik Technology ranks #673 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 84.5%.
Is Bioptik Technology's Days Payable too high?
Bioptik Technology's current Days Payable of 29.46 is 45% below median its 10-year median of 53.17. Over the past 10 years, this metric has ranged from a low of 30.51 to a high of 62.16. The Medical Devices & Instruments industry median Days Payable is 67.97. Bioptik Technology's value of 29.46 is 56.7% below this industry median. Based on the distribution chart, Bioptik Technology ranks #673 out of 796 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bioptik Technology has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioptik Technology's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bioptik Technology ranks #673 out of 796 companies for Days Payable. This places Bioptik Technology in the lower half of its industry. The industry median Days Payable is 67.97. Bioptik Technology's value of 29.46 is 56.7% below this benchmark. Historically, Bioptik Technology's own Days Payable has ranged from 30.51 to 62.16 over the past decade. While the company's 10-year median is 53.17 vs. the industry median of 67.97, Bioptik Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioptik Technology's current Days Payable of 29.46 is 56.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bioptik Technology and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioptik Technology's current Days Payable is 29.46, which is 45% below median its own 10-year median of 53.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioptik Technology stock overvalued right now?
Based on GuruFocus' analysis, Bioptik Technology (ROCO:4161) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.79, compared to a current price of NT$23.00 — trading 17.2% below its estimated fair value. The current Days Payable is 29.46, which is 45% below median its 10-year median of 53.17 and 56.7% below the Medical Devices & Instruments industry median of 67.97. Bioptik Technology's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bioptik Technology (ROCO:4161), the current Days Payable is 29.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioptik Technology (ROCO:4161) Overvalued in 2026?
Based on GuruFocus' analysis, Bioptik Technology stock appears to be undervalued.
The current stock price of NT$23.00 is trading 17.2% below its estimated GF Value™ of NT$27.79.
GuruFocus considers Bioptik Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4161:
Days Payable: 29.46 (45% below median its 10-year median of 53.17)
GF Value™: NT$27.79 vs. price of NT$23.00 (17.2% below fair value)
Industry Position: 56.7% below the Medical Devices & Instruments median (#673 of 796)
No single metric tells the full story. See the ROCO:4161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
68GF Score
Get the complete analysis for ROCO:4161
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4161 has been successfully added to your 
